---
title: "阿斯利康和安進獲得美國 FDA 批准用於治療慢性鼻竇炎伴鼻息肉（CRSwNP）"
description: "阿斯利康和安進獲得美國 FDA 批准用於 CRSwNP 治療"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/261744744.md"
published_at: "2025-10-19T05:50:33.000Z"
---

# 阿斯利康和安進獲得美國 FDA 批准用於治療慢性鼻竇炎伴鼻息肉（CRSwNP）

> 阿斯利康和安進獲得美國 FDA 批准用於 CRSwNP 治療

### Related Stocks

- [AZN.US - 阿斯利康](https://longbridge.com/zh-HK/quote/AZN.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Chinese Authorities Charge AstraZeneca's Ex-China Business Head | Chinese Authorities Charge AstraZeneca's Ex-China Business Head | [Link](https://longbridge.com/zh-HK/news/275632182.md) |
| Astrazeneca Expects 2026 Core EPS To Increase By Low Double-Digit Percentage | AstraZeneca PLC expects its core EPS to rise by a low double-digit percentage in 2026. The company anticipates total rev | [Link](https://longbridge.com/zh-HK/news/275415782.md) |
| What's Driving the Market Sentiment Around AstraZeneca PLC? | AstraZeneca PLC's short interest has surged by 125.71%, with 12.27 million shares sold short, representing 0.79% of avai | [Link](https://longbridge.com/zh-HK/news/275609087.md) |
| Envestnet Asset Management Inc. Purchases 293,113 Shares of AstraZeneca PLC $AZN | Envestnet Asset Management Inc. increased its stake in AstraZeneca PLC by 8.2% in Q3, acquiring 293,113 shares, bringing | [Link](https://longbridge.com/zh-HK/news/274981161.md) |
| AstraZeneca schließt strategische Kooperationsvereinbarung mit CSPC Pharmaceuticals über globale Rechte an Gewichtmanagement-Portfolio | AstraZeneca plc has announced a strategic cooperation agreement with CSPC Pharmaceuticals for global rights to its weigh | [Link](https://longbridge.com/zh-HK/news/275453051.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。
